The techie shared the rules on the r/Bangalore subreddit adding that these were his observations from working at three unicorn startups ... feels like navigating a maze blindfolded.

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...